Penumbra
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
PEN Key Statistics
Stock Snapshot
With a market cap of 10.93B, Penumbra(PEN) trades at $278.74. The stock has a price-to-earnings ratio of 66.61.
On 2025-11-14, Penumbra(PEN) stock moved within a range of $274.20 to $280.85. With shares now at $278.74, the stock is trading +1.7% above its intraday low and -0.8% below the session's peak.
Trading activity shows a volume of 444.54K, compared to an average daily volume of 584.35K.
The stock's 52-week range extends from a low of $221.26 to a high of $310.00.
The stock's 52-week range extends from a low of $221.26 to a high of $310.00.
PEN News
Penumbra, Inc. recently reported third quarter results with sales reaching US$354.69 million and net income rising to US$45.85 million, alongside raising its 20...
Penumbra, Inc. PEN reported third-quarter 2025 adjusted earnings per share (EPS) of 97 cents, which surpassed the Zacks Consensus Estimate by 7.78%. Adjusted EP...
